Navigation Links
Halozyme Reports First Quarter 2012 Financial Results
Date:5/7/2012

rovide a corporate overview.

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Halozyme Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Safe Harbor Statement In addition to historical information, the statements set forth above include forward-looking statements including, without limitation, statements concerning the EPO's anticipated issuance of a final written decision regarding our European patent for rHuPH20, Roche's anticipated filing of the Line Extension Application of subcutaneous MabThera® (rituxumab with rHuPH20) to the European Medicines Agency this year, our anticipated cash burn for 2012  and potential benefits and attributes of our product candidates. These statements involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Halozyme to Host First Quarter 2012 Financial Results Conference Call
2. ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20)
3. Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
4. Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock
5. Halozyme Announces Proposed Public Offering of Common Stock
6. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
7. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
8. Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting
9. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
10. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
11. ViroPharma and Halozyme Therapeutics Announce Initiation of Phase 2 Evaluation of Subcutaneous Delivery of Cinryze® (C1 Esterase Inhibitor [Human]) with Hyaluronidase (rHuPH20)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... WASHINGTON , July 29, 2015  The ... campaign to improve understanding of the advantages, limitations ... prenatal screening and other diagnostic tests for pregnant ... DGX ), the world,s leading provider of ... to support the initiative, through a grant. ...
(Date:7/29/2015)... , July 29, 2015 At the ... researchers will present findings that a first-of-its-kind smartphone ... high accuracy, which could reduce the prevalence of ... screening easier and cheaper. Most people ... the infection often causes no symptoms, but if ...
(Date:7/29/2015)... , July 29, 2015 Pulmatrix, ... investor presentation August 6, 2015 at 10:45 am ... Clarke , Chief Executive Officer, will review Pulmatrix,s ... Company,s pipeline of inhaled therapeutics based on their ... Date:     Thursday, August 6, 2015 Time:    10:45 ...
Breaking Medicine Technology:Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 2Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 3Quest Diagnostics Collaborates with Perinatal Quality Foundation on National Initiative to Advance Clinically Appropriate Noninvasive Prenatal Screening 4First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 2First Smartphone DNA Test for Chlamydia to Be Presented at 2015 AACC Annual Meeting 3Pulmatrix to Webcast Investor Presentation and Provide Update on Pipeline of Inhaled Therapeutics August 6th 2
... , ATLANTA , ... new corporate Web site that provides healthcare professionals, patients, investors ... browse information about Elekta,s solutions for treating cancer and brain ... Elekta.com offers increased functionality, including a new, clean design ...
... , FORT WORTH, Texas , ... WNDM) announced today that it has completed the acquisition of secure ... technology assets from VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) as ... addition to the acquisition of Secure eHealth, Wound Management has also ...
Cached Medicine Technology:Elekta Launches New Web Site for Global Health Care Community 2Elekta Launches New Web Site for Global Health Care Community 3Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 2Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 3Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 4Wound Management Technologies Completes Acquisition of Secure eHealth, LLC and Other Assets from VirtualHealth Technologies; Robert Tapales Appointed President of Secure eHealth, LLC 5
(Date:7/29/2015)... ... July 29, 2015 , ... VideoLink , ... Medical Center, located in New York, NY, selected the ReadyCam on-site video studio ... and scientists to immediately access worldwide TV and cable news networks and participate ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... discrimination and health inequities. Since 2012, Massachusetts law has provided legal protections against ... business. However, the law does not protect against discrimination based on gender identity ...
(Date:7/29/2015)... Vancouver, BC (PRWEB) , ... July 29, 2015 , ... ... commencement of its new service: water damage restoration of carpets and rugs. The company ... as well as for commercial clients. , An overflowing overhead tank, rain leaking ...
(Date:7/29/2015)... ... July 29, 2015 , ... The healthcare analytics market ... and region. Factors such as the rising pressure to curb healthcare costs, big ... in venture capital investments are driving market growth. Check 149 data tables & ...
(Date:7/29/2015)... ... July 29, 2015 , ... On July 26th the ... the FDA for nicotine laced liquid products. Their report says cigarette use has ... E-Cigarettes are particularly troublesome to addiction professionals as many of the candy flavors ...
Breaking Medicine News(10 mins):Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 2Health News:Columbia University Medical Center Installs a VideoLink ReadyCam® Video Studio on Campus; Medical Experts Able to Appear on Live TV at a Moment's Notice 3Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 2Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 3Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 4Health News:Healthcare Analytics Market Growing at 26.5% CAGR to 2020 5Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3
... The National Board of Certification for Medical Interpreters will ... will be part of the testing for National Medical ... will "test the test" designed to verify the ability ... real-life medical interpreting scenarios. This process will provide additional ...
... Charles R. Evans and Reynold J. Jennings to the Advisory Board ... allied health staffing, hospital management and healthcare information technology solutions to ... ... GA (Vocus) May 22, 2009 -- Jackson Healthcare ...
... training, Diane Castelli appointed to represent nurses worldwide in advancing the ... ... May 22, 2009 -- AMD Global Telemedicine Inc. announces Diane Castelli, ... the American Telemedicine Association,s (ATA) Telehealth Nursing Special Interest Group (SIG). ...
... Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy ... make a dramatic difference in treating CRT patients." Dr. Abraham ... the University of Illinois at Chicago. , ... ...
... study finds that nearly one in four African American women ... potentially life saving therapies. Published in the July 1, 2009 ... American Cancer Society, the study indicates that more efforts are ... appropriate care. , In the United States, African American women ...
... 21 Biotechnology firm Viral Genetics, Inc. (Pink Sheets: ... to treat cancer, Lyme Disease and HIV, has been ... protects cancer drugs that have been tested in pre-clinical ... the U.S. Patent Number is: 7,510,710. Additional patents directed ...
Cached Medicine News:Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 2Health News:National Medical Interpreter Certification Testing Enters Pilot Phase 3Health News:Two Executives Join Jackson Healthcare Advisory Board 2Health News:Two Executives Join Jackson Healthcare Advisory Board 3Health News:AMD Global Telemedicine Inc., Proud to Announce Diane Castelli, Chair of the American Telemedicine Association's (ATA) Telehealth Nursing Special Interest Group (SIG) 2Health News:Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy During Exercise 2Health News:Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy During Exercise 3Health News:Heart Rhythm Society Introduced to New Method for Optimizing Cardiac Resynchronization Therapy During Exercise 4Health News:African-American women with advanced breast cancer often forego vital treatment 2Health News:Viral Genetics Has Option Under Issued Key Patent for Cancer Drug 2Health News:Viral Genetics Has Option Under Issued Key Patent for Cancer Drug 3Health News:Viral Genetics Has Option Under Issued Key Patent for Cancer Drug 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: